NCT03814109 - Efficacy and Safety of Leningrado Association in the Treatment of Hypertension | Biotech Hunter

Timeline

Start Date

April 30, 2022

Primary Completion Date

November 30, 2023

Study Completion Date

January 31, 2024

Conditions

Arterial Hypertension

Interventions

DRUG

LENINGRADO association

1 coated sustained-release tablet, oral, once a day.

DRUG

Indapamide SR 1.5 MG

1 coated sustained-release tablet, oral, once a day.

DRUG

Levamlodipine 2.5/ 5 mg

1 tablet, oral, once a day.

OTHER

Leningrado association Placebo

1 coated sustained-release tablet, oral, once a day.

OTHER

Indapamide SR Placebo

1 coated sustained-release tablet, oral, once a day.

OTHER

Levamlodipine placebo

1 tablet, oral, once a day.